The end of the road for TRUS biopsy? TRANSLATE trial reads out

We are thrilled to drop this pod just as the landmark TRANSLATE trial reads out at the EAU Annual Meeting in Madrid, with a simultaneous publication in Lancet Oncology. This is the world's largest trial of transrectal vs transperineal (TP) prostate biopsy, and reports that TP biopsy has superior cancer detection ability. Is this the end of the road for TRUS biopsy.

Hosts Declan Murphy and Renu Eapen are delighted to welcome first and senior authors, Prof Richard Bryant and Dr Alastair Lamb of the University of Oxford to have a detailed discussion about TRANSLATE and what this means for prostate biopsy.

Also available as an audio podcast, just search GU Cast wherever you get yours.

Links:

Full Lancet Oncology paper

Funders:

NIHR HTA

Also available as an audio podcast, just search GU Cast wherever you get yours